USPTO serial 86868085
VAYA PHARMA
Reviewed by CopyMark Law Group
Reg. 5094124Status 710
- Filing date
- Status date
- Registration date
- Dec 6, 2016
- Examiner
- BORSUK, ESTHER
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with VAYA PHARMA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Kfar Baruch, IL
Kfar Baruch, IL
Kfar Baruch, IL
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jacqueline Zion
JACQUELINE ZION PEARL COHEN ZEDEK LATZER BARATZ LLP1500 BROADWAY, 12TH FLNEW YORK, NY 10036UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Dietary supplements; medical foods for dietary management of diseases and conditions; pharmaceuticals, namely, pharmaceutical preparations for the treatment or prevention of Attention Deficit Disorder (ADD)/Attention Deficit Hyperactivity Disorder (ADHD), dyslexia, learning disorders, stress, anxiety, Sleep, epilepsy, concentration and attention impairment and mood deterioration; pharmaceutical preparations for the treatment and prevention of diseases and conditions associated with lipid metabolism, hyperlipidemia and hypertriglyceridemia as reducing serum levels of both cholesterol and triglycerides, and for the treatment and prevention of cardiovascular disease (CVD) and coronary heart disease (CHD) as reducing oxidation levels of serum low density lipoproteins (LDL) and macrophage, and by reducing inflammation and hypertension; pharmaceuticals, namely, pharmaceutical preparations for the treatment or prevention of age-associated memory impairment, mild cognitive impairment, pre-Alzheimer's disease, Alzheimer's disease, predementia syndrome, dementia, subjective cognitive decline, early memory impairment, and age related cognitive decline | SECTION 8 - CANCELLED | Mar 28, 2011 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 16, 2023 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Dec 6, 2021 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Dec 6, 2016 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 20, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 20, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 31, 2016 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 10, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 10, 2016 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 10, 2016 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 10, 2016 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 10, 2016 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 9, 2016 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Jul 19, 2016 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Jul 1, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 24, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 23, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 23, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 2, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 2, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 2, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 25, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 15, 2016 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Jan 14, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 11, 2016 | NWAP | NEW APPLICATION ENTERED | — |